- Report
- August 2025
- 182 Pages
Global
From €3179EUR$3,545USD£2,750GBP
€3533EUR$3,939USD£3,056GBP
- Report
- January 2026
- 196 Pages
Global
From €3179EUR$3,545USD£2,750GBP
€3533EUR$3,939USD£3,056GBP
- Report
- January 2026
- 186 Pages
Global
From €3179EUR$3,545USD£2,750GBP
€3533EUR$3,939USD£3,056GBP
- Report
- August 2025
- 184 Pages
Global
From €3179EUR$3,545USD£2,750GBP
€3533EUR$3,939USD£3,056GBP
- Report
- February 2026
- 250 Pages
Global
From €4027EUR$4,490USD£3,483GBP
- Report
- March 2026
- 369 Pages
Global
From €5246EUR$5,850USD£4,539GBP
- Report
- May 2022
- 211 Pages
Global
From €4439EUR$4,950USD£3,840GBP
- Report
- July 2024
- 155 Pages
Global
From €3240EUR$3,613USD£2,803GBP
€3812EUR$4,250USD£3,297GBP
- Report
- June 2022
- 254 Pages
Global
From €3229EUR$3,600USD£2,793GBP
- Report
- September 2023
- 88 Pages
Global
From €3500EUR$4,181USD£3,134GBP
The Cryostat Microtome is a laboratory equipment used for the preparation of frozen sections of biological tissue samples. It is used in histology, pathology, and medical research. The Cryostat Microtome is a specialized instrument that uses a freezing process to cut thin slices of tissue for microscopic examination. It is a precision instrument that requires a high level of skill and experience to operate.
The Cryostat Microtome market is a niche market within the larger laboratory equipment market. It is used in a variety of medical and research applications, and is an essential tool for histology and pathology laboratories. The Cryostat Microtome market is highly competitive, with a number of manufacturers offering a range of products.
Some of the companies in the Cryostat Microtome market include Leica Biosystems, Sakura Finetek, Thermo Fisher Scientific, and SLEE Medical. Show Less Read more